Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells. [electronic resource]
Producer: 20190110Description: 4447 p. digitalISSN:- 2045-2322
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Calcium -- metabolism
- Cell Line, Tumor
- Cytosol -- metabolism
- Gene Duplication
- Humans
- Imipramine -- pharmacology
- Leukemia, Myeloid, Acute -- genetics
- Lysosomes -- metabolism
- Mitochondria -- drug effects
- Reactive Oxygen Species -- metabolism
- STAT5 Transcription Factor -- metabolism
- Tandem Repeat Sequences
- fms-Like Tyrosine Kinase 3 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.